Niagen Bioscience, Inc. (NAGE)

Market Cap	726.90M
Revenue (ttm)	107.93M
Net Income (ttm)	14.11M
Shares Out	78.67M
EPS (ttm)	0.18
PE Ratio	84.00
Forward PE	85.32
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,042,816
Open	8.89
Previous Close	8.45
Day's Range	8.67 - 9.50
52-Week Range	2.31 - 9.50
Beta	1.95
Analysts	Strong Buy
Price Target	11.00 (+19.05%)
Earnings Date	May 7, 2025

About NAGE

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and ph...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 104
• Stock Exchange: NASDAQ
• Ticker Symbol: NAGE
• Website: https://www.niagenbioscience.com

Analyst Forecast

According to one analyst, the rating for NAGE stock is "Strong Buy" and the 12-month stock price forecast is $11.0.

Price Target

$11.0

(19.05% upside)

Analyst Consensus: Strong Buy